Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001300062 | SCV001489186 | likely benign | not provided | 2024-06-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001300062 | SCV002027909 | uncertain significance | not provided | 2021-11-19 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004699288 | SCV005202907 | uncertain significance | not specified | 2024-07-23 | criteria provided, single submitter | clinical testing | Variant summary: ADGRV1 c.16999A>T (p.Met5667Leu) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 3.9e-05 in 155220 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.16999A>T in individuals affected with ADGRV1-Related Disorders and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 1003501). Based on the evidence outlined above, the variant was classified as uncertain significance. |